Circulating Tumor DNA Profiling Across Phase II/III Ewing Sarcoma Trials Identifies High-Risk Patients with TP53, STAG2, and CDKN2A Alterations.
Read the full article. https://t.co/FPmFXzBRVj
찬장 문에 기댄 찻잔 꺼내겠다고 이렇게까지 하는 일본 예능ㅋㅋㅋ☕️🇯🇵
문을 열면 쏟아질 것 같은 찻잔들.
이걸 안 깨뜨리고 꺼내려고 모형까지 만들어서 실험함ㅋㅋㅋ
처음엔 “이게 방송할 일이야?” 싶었는데
어느새 나도 어떻게 꺼낼지 진지하게 고민하고 있음😂
개인적으로 요즘 비슷한 출연진에 익숙한 레퍼토리가 반복되는 한국 예능보다, 이런 엉뚱한 문제 하나에 끝까지 몰입하는 일본 예능이 더 재밌어 보임🙄
거창한 설정 없이도
찻잔 몇 개로 사람을 이렇게 집중시키네ㅋㅋㅋ
A lot of the key details of this study point towards the result not being real.
I think we ought to regard it as fraudulent until proven real🧵
To start, the result is as strong as the observational results from the earlier literature. That's very unusual for a trial!
📢📢ERBB2 alterations on molecular profiling CANNOT replace testing by IHC📢📢
HER2 IHC 3+ 80.47% ERBB2 amplified
HER2 IHC2+ only 5.69% ERBB2 amplified
HER2 IHC1+ only 0.40% ERBB2 amplified
(Numbers are worse w ERBB2 mut)
TY @TimothyJBrownMD for your attn to this matter
Maritime agencies Diaplous and Ambrey say they had ended their search for the remaining crew of the #EternityC cargo ship that was attacked by Yemen’s Houthi militants last week. #Houthis
https://t.co/M3z8Vx2oib